These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 11314780)
1. DNA topoisomerase II-alpha in pulmonary carcinoid tumors. Resl M; Simek J; Bukac J; Rothröckel P; Siller J Pathol Res Pract; 2001; 197(3):169-73. PubMed ID: 11314780 [TBL] [Abstract][Full Text] [Related]
2. [Typical and atypical pulmonary carcinoids--pathologic and clinical analysis of 77 cases]. Słodkowska J; Langfort R; Rudziński P; Kupis W Pneumonol Alergol Pol; 1998; 66(5-6):297-303. PubMed ID: 9857650 [TBL] [Abstract][Full Text] [Related]
3. [Proliferative activity in pulmonary carcinoids]. Resl M; Bukac J; Simek J; Siller J; Rothröckel P Cesk Patol; 2000 Jan; 36(1):32-4. PubMed ID: 10838756 [TBL] [Abstract][Full Text] [Related]
4. Alteration of the E-cadherin/beta-catenin cell adhesion system is common in pulmonary neuroendocrine tumors and is an independent predictor of lymph node metastasis in atypical carcinoids. Pelosi G; Scarpa A; Puppa G; Veronesi G; Spaggiari L; Pasini F; Maisonneuve P; Iannucci A; Arrigoni G; Viale G Cancer; 2005 Mar; 103(6):1154-64. PubMed ID: 15712207 [TBL] [Abstract][Full Text] [Related]
5. Correlation between p53, c-erbB-2, and topoisomerase II alpha expression, DNA ploidy, hormonal receptor status and proliferation in 356 node-negative breast carcinomas: prognostic implications. Rudolph P; Olsson H; Bonatz G; Ratjen V; Bolte H; Baldetorp B; Fernö M; Parwaresch R; Alm P J Pathol; 1999 Jan; 187(2):207-16. PubMed ID: 10365096 [TBL] [Abstract][Full Text] [Related]
6. Typical and atypical carcinoid tumours: analysis of the experience of the Spanish Multi-centric Study of Neuroendocrine Tumours of the Lung. García-Yuste M; Matilla JM; Cueto A; Paniagua JM; Ramos G; Cañizares MA; Muguruza I; Eur J Cardiothorac Surg; 2007 Feb; 31(2):192-7. PubMed ID: 17196822 [TBL] [Abstract][Full Text] [Related]
7. Topoisomerase IIalpha expression in breast cancer: correlation with outcome variables. Depowski PL; Rosenthal SI; Brien TP; Stylos S; Johnson RL; Ross JS Mod Pathol; 2000 May; 13(5):542-7. PubMed ID: 10824926 [TBL] [Abstract][Full Text] [Related]
9. Carcinoid tumor of the lung: clinicopathological study of 32 cases. Akiba T; Naruke T; Kondo H; Goya T; Tsuchiya R; Suemasu K; Noguchi M; Sakurai K Jpn J Clin Oncol; 1992 Apr; 22(2):92-5. PubMed ID: 1619783 [TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical and two-parameter flow cytometric studies of DNA topoisomerase II alpha in human epithelial ovarian carcinoma and germ cell tumor. Tanoguchi K; Sasano H; Yabuki N; Kikuchi A; Ito K; Sato S; Yajima A Mod Pathol; 1998 Feb; 11(2):186-93. PubMed ID: 9504690 [TBL] [Abstract][Full Text] [Related]
11. Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome. Przygodzki RM; Finkelstein SD; Langer JC; Swalsky PA; Fishback N; Bakker A; Guinee DG; Koss M; Travis WD Am J Pathol; 1996 May; 148(5):1531-41. PubMed ID: 8623922 [TBL] [Abstract][Full Text] [Related]
12. [Clinicopathological features and prognosis of different gastric carcinoid subtypes]. Liang JW; Zhou ZX; Liu Q; Bai XF; Zhao P Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):866-9. PubMed ID: 19173835 [TBL] [Abstract][Full Text] [Related]
13. Primary carcinoid tumor of the middle ear: a potentially metastasizing tumor. Ferlito A; Devaney KO; Rinaldo A Acta Otolaryngol; 2006 Mar; 126(3):228-31. PubMed ID: 16618645 [TBL] [Abstract][Full Text] [Related]
15. Interobserver variability for the WHO classification of pulmonary carcinoids. Swarts DR; van Suylen RJ; den Bakker MA; van Oosterhout MF; Thunnissen FB; Volante M; Dingemans AM; Scheltinga MR; Bootsma GP; Pouwels HM; van den Borne BE; Ramaekers FC; Speel EJ Am J Surg Pathol; 2014 Oct; 38(10):1429-36. PubMed ID: 25046341 [TBL] [Abstract][Full Text] [Related]
16. Comparison of DNA topoisomerase II alpha expression in small cell and nonsmall cell carcinoma of the lung. In search of a mechanism of chemotherapeutic response. Guinee DG; Holden JA; Benfield JR; Woodward ML; Przygodzki RM; Fishback NF; Koss MN; Travis WD Cancer; 1996 Aug; 78(4):729-35. PubMed ID: 8756364 [TBL] [Abstract][Full Text] [Related]
17. The Role of Histologic Grading and Ki-67 Index in Predicting Outcomes in Pulmonary Carcinoid Tumors. Dermawan JKT; Farver CF Am J Surg Pathol; 2020 Feb; 44(2):224-231. PubMed ID: 31490236 [TBL] [Abstract][Full Text] [Related]
18. Topoisomerase II alpha expression in squamous cell carcinomas of the head and neck. Stathopoulos GP; Kapranos N; Manolopoulos L; Papadimitriou C; Adamopoulos G Anticancer Res; 2000; 20(1A):177-82. PubMed ID: 10769652 [TBL] [Abstract][Full Text] [Related]
19. Comparative evaluation of three proliferation markers, Ki-67, TOP2A, and RacGAP1, in bronchopulmonary neuroendocrine neoplasms: Issues and prospects. Neubauer E; Wirtz RM; Kaemmerer D; Athelogou M; Schmidt L; Sänger J; Lupp A Oncotarget; 2016 Jul; 7(27):41959-41973. PubMed ID: 27259241 [TBL] [Abstract][Full Text] [Related]